News
FDA Expands Vertex's Casgevy Approval to Children with Sickle Cell Disease
1+ hour, 57+ min ago (69+ words) Voice of Healthcare The gene therapy is now approved for children as young as two years with sickle cell disease and transfusion-dependent beta thalassemia. Gavi launches supply chain strategy to improve vaccine availability FDA Expands Vertex's Casgevy Approval to Children…...
President calls on all institutions to act in line with national plan to eradicate drug menace
24+ min ago (740+ words) President Anura Kumara Dissanayake emphasised that all relevant institutions must operate in accordance with a national plan in order to eradicate the drug menace. The President made these remarks while attending the meeting of the "A Nation United" National Steering…...
Eligible seniors can get GLP-1s for $50 a month for weight loss alone
1+ day, 2+ min ago (505+ words) (NEW YORK) " For the first time, Medicare will cover GLP-1s for obesity-related weight loss, without any other medical conditions. Starting Wednesday, eligible Medicare beneficiaries can receive GLP-1s for obesity for $50 per month by prescription. Medicare is the primary federal health…...
Statins May Lower Cardiovascular Risk in Obese Adults
20+ min ago (562+ words) They will continue to face other risks associated with obesity, such as diabetes, kidney and liver diseases, and cancer The findings were most striking in older adults (6079 years old) with obesity. They had similar or even lower blood pressure and…...
Medicare's New $50 GLP-1 Weight-Loss Program Just Launched: Find Out if You Qualify
27+ min ago (913+ words) For the first time in the program's history, Medicare is now covering prescription weight-loss drugs for eligible seniors, not just when those medications are prescribed for diabetes or heart disease, but specifically for obesity. The Medicare GLP-1 Bridge, a pilot…...
Pharmalittle: We're reading about a court win for Amgen, Novo seeking supplier discounts, and more
31+ min ago (351+ words) STAT Pharmalittle: We're reading about a court win for Amgen, Novo seeking supplier discounts, and more Millions more Americans will qualify for obesity drugs at $50 a month under a new Medicare program Pharmalot Columnist, Senior Writer Ed's stories explore prescription…...
A new Medicare program will give 3 million older adults access to GLP-1 weight loss drugs starting July 1 " but there's a catch - AOL
1+ hour, 44+ min ago (807+ words) GLP-1 drugs, also called semaglutide (but better known by brand names like Ozempic, Wegovy and Zepbound), have exploded in popularity in recent years. Originally marketed as a treatment for Type 2 diabetes, they have also been used for weight loss " for…...
FDA Approves Casgevy Gene Therapy for Young Children
1+ hour, 36+ min ago (440+ words) All Sci The US FDA has supplementally approved Casgevy (exagamglogene autotemcel) for patients aged 2 years and older with sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent "-thalassemia (TDT) " marking the first gene therapy approved for young children…...
Genentech's Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12 C Inhibitors in Non-Small Cell Lung Cancer
8+ hour, 47+ min ago (328+ words) Efficacious treatments for KRAS G12 C NSCLC represent a significant unmet need in lung cancer care. The G12 C mutation is one of the most common KRAS oncogene mutations, found in approximately 14% of NSCLC cases and associated with poor prognosis for patients....
FDA Expands Gene Therapy for Younger Patients
24+ min ago (331+ words) Conexiant The US Food and Drug Administration has approved an expanded indication for exagamglogene autotemcel (CASGEVY) to include patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia, according to a press release…...